PATANOL

This brand name is authorized in Brazil, Canada, Ecuador, Israel, Japan, Mexico, New Zealand, Singapore, Turkey, United States, South Africa

Active ingredients

The drug PATANOL contains one active pharmaceutical ingredient (API):

1 Olopatadine UNII 2XG66W44KF - OLOPATADINE HYDROCHLORIDE

Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action. Read about Olopatadine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PATANOL Eye drops, solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GX09	Olopatadine	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500903101175310, 500904601171411
Country: CA	Health Products and Food Branch	Identifier(s): 02233143
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.610-03-04, 28554-09-08
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4866
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319752Q1024
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 463M98
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10163
Country: SG	Health Sciences Authority	Identifier(s): 10485P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504612073
Country: US	FDA, National Drug Code	Identifier(s): 0065-0271
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/15.4/0189